Corrigendum: Galectin-9: A Suppressor of Atherosclerosis?

Jian Yu,Ruirui Zhu,Kunwu Yu,Yue Wang,Yan Ding,Yucheng Zhong,Qiutang Zeng

DOI: https://doi.org/10.3389/fimmu.2021.686592

IF: 7.3

2021-04-13

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.604265.].

immunology

What problem does this paper attempt to address?

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Ke Meng,Huacong Cai,Simin Cai,Yucai Hong,X Zhang

DOI: https://doi.org/10.3389/fcell.2023.997572

IF: 5.5

2023-01-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.644160.].
Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Pingping Ren,Luying Lu,Shasha Cai,Jianghua Chen,Weiqiang Lin,Fei Han

DOI: https://doi.org/10.3389/fimmu.2024.1513491

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.713540.].
Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]

Xiaohua Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Feng Shi,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

IF: 7.376

2022-01-01

Genes & Diseases

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].
Corrigendum: C1q/TNF-Related Protein 9 Attenuates Atherosclerosis by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the AMPKα/KLF4 Signaling Pathway

Gang Wang,Baihe Han,Ruoxi Zhang,Qi Liu,Xuedong Wang,Xingtao Huang,Dandan Liu,Weishen Qiao,Mengyue Yang,Xing Luo,Jingbo Hou,Bo Yu

DOI: https://doi.org/10.3389/fphar.2021.812384

IF: 5.6

2021-12-15

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.758792.].

pharmacology & pharmacy
Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Hangying Ying,Hongdi Yuan,Xiaomei Tang,Wenpu Guo,Ruhong Jiang,Chenyang Jiang

DOI: https://doi.org/10.3389/fcvm.2021.723626

IF: 3.6

2021-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.641062.].
Corrigendum: LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease via Skewing Allogeneic T Cells Polarization Towards Treg Cells

Huihui Liu,Zhengyu Yu,Bo Tang,Shengchao Miao,Chenchen Qin,Yuan Li,Zeyin Liang,Yongjin Shi,Yang Zhang,Qingya Wang,Miao Yan,Zhengyang Song,Hanyun Ren,Yujun Dong

DOI: https://doi.org/10.3389/fimmu.2021.762728

2021-09-16

Abstract:[This corrects the article DOI: 10.3389/fimmu.2021.647894.].
Corrigendum: CircAFF1 aggravates vascular endothelial cell dysfunction mediated by miR-516b/SAV1/YAP1 axis

Hong-guang Wang,Hua Yan,Chen Wang,Mi-mi Li,Xin-ze Lv,Hai-dong Wu,Zhan-hai Fang,Dong-li Mo,Zhi-yuan Zhang,Bin Liang,Ke-guan Lai,Jing-yu Bao,Xue-jia Yang,Hong-juan Zhao,Shuang Chen,Yi-mu Fan,Xiao-guang Tong

DOI: https://doi.org/10.3389/fphys.2022.881750

IF: 4

2022-07-22

Frontiers in Physiology

Abstract:[This corrects the article DOI: 10.3389/fphys.2020.00899.].

physiology
Corrigendum: Myocardial Viability, Functional Status, and Collaterals of Patients With Chronically Occluded Coronary Arteries

Xueyao Yang,Jinfan Tian,Lijun Zhang,Wei Dong,Hongzhi Mi,Jianan Li,Jiahui Li,Ye Han,Huijuan Zuo,Jing An,Yi He,Xiantao Song

DOI: https://doi.org/10.3389/fcvm.2022.877972

IF: 3.6

2022-01-01

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.754826.].
Corrigendum to"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment" [Bioact Mater 24 (2022) 37-53]

Haotian Shen,Lulu Jin,Qiangqiang Zheng,Ziqiang Ye,Linxiang Cheng,Yuxu Wu,Honghao Wu,Tae Gyong Jon,Wenduo Liu,Zongyou Pan,Zhengwei Mao,Yue Wang

DOI: https://doi.org/10.1016/j.bioactmat.2024.08.007

2024-08-22

Abstract:[This corrects the article DOI: 10.1016/j.bioactmat.2022.12.001.].
Corrigendum: Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6+ natural killer T cells

Tao Li,Xinlong Lin,Binhai Shen,Wujian Zhang,Yangyang Liu,Hongbin Liu,Ye Wang,Lijun Zheng,Fachao Zhi

DOI: https://doi.org/10.3389/fimmu.2023.1139000

IF: 7.3

2023-02-22

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.1047570.].

immunology
Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Xiujin Shen,Chunhua Weng,Yucheng Wang,Cuili Wang,Shi Feng,Xiayu Li,Heng Li,Hong Jiang,Haibing Wang,Jianghua Chen

DOI: https://doi.org/10.1016/j.gendis.2022.03.001

2022-03-01

Abstract:[This corrects the article DOI: 10.1016/j.gendis.2020.07.005.][This corrects the article DOI: 10.1016/j.gendis.2021.09.001.].

genetics & heredity,biochemistry & molecular biology
Corrigendum: the Adipocyte and Adaptive Immunity

Jianfeng Song,Tuo Deng

DOI: https://doi.org/10.3389/fimmu.2021.784125

IF: 7.3

2021-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2020.593058.].
Galectin-9: A Suppressor of Atherosclerosis?

Jian Yu,Ruirui Zhu,Kuwu Yu,Yue Wang,Yan Ding,Yucheng Zhong,Qiutang Zeng,Kunwu Yu

DOI: https://doi.org/10.3389/fimmu.2020.604265

IF: 7.3

2020-11-04

Frontiers in Immunology

Abstract:It is no longer controversial that atherosclerosis is a vascular wall chronic inflammatory disease mediated by cells of innate and adaptive immunity. Galectin-9 (Gal-9) seems to be a crucial regulator of T-cell immunity by inducing apoptosis in specific T-cell subpopulations associated with autoimmunity and inflammatory disease. Accumulating evidence showed that galectin-9 signaling via T-cell immunoglobulin mucin 3 (TIM-3) is concerned with different regulatory functions in autoimmunity, including direct depletion of pro-inflammatory T-cells, expanding the number of regulatory T cells, altering macrophages to an anti-inflammatory state and the induction of repressive myeloid-derived suppressor cells. In addition, anti-Tim-3-Ab administration increased atherosclerotic plaque formation by blocking Tim-3–galectin-9 interaction. Hence, we hypothesize that galectin-9 may be a novel therapy for atherosclerotic disease. Further researches are needed to investigate the precise effect of galectin-9 in the process of atherosclerosis.

immunology
Corrigendum: The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into Atherosclerosis: A Mini Review

Mengqi Li,Qingzheng Jiao,Wenqiang Xin,Shulin Niu,Mingming Liu,Yanxin Song,Zengguang Wang,Xinyu Yang,Degang Liang

DOI: https://doi.org/10.3389/fcvm.2022.850258

IF: 3.6

2022-01-31

Frontiers in Cardiovascular Medicine

Abstract:[This corrects the article DOI: 10.3389/fcvm.2021.782098.].

cardiac & cardiovascular systems
Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.

Hao Zhang,Minna Luo,Xi Liang,Dan Wang,Xin Gu,Chao Duan,Huizi Gu,Guanglei Chen,Xinhan Zhao,Zuowei Zhao,Caigang Liu

DOI: https://doi.org/10.1371/journal.pone.0232166

IF: 3.7

2020-01-01

PLoS ONE

Abstract:[This corrects the article DOI: 10.1371/journal.pone.0103482.].
Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2

Hai-yun Li,Ning Gao,Cheng-yang Liu,Xiao-ling Liu,Feng Wu,Nini Dai,Jing Han,Qiu-yu Li

DOI: https://doi.org/10.3389/fimmu.2022.1011789

IF: 7.3

2022-09-12

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.918731.].

immunology
Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Haibo Xing,Mengting Tong,Jing Wang,Hanqing Hu,Chongya Zhai,Chunhui Huang,Da Li

DOI: https://doi.org/10.1155/2022/9767389

2022-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/3195025.].
Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

Yan-Mei Wang,Shou-Ling Mi,Hong Jin,Qi-Lin Guo,Zhong-Yu Yu,Jian-Tao Wang,Xiao-Ming Zhang,Qian Zhang,Na-Na Wang,Yan-Yan Huang,Hou-Guang Zhou,Jing-Chun Guo

DOI: https://doi.org/10.3389/fphar.2021.827490

IF: 5.6

2022-01-03

Frontiers in Pharmacology

Abstract:[This corrects the article DOI: 10.3389/fphar.2021.754387.].

pharmacology & pharmacy
Corrigendum to “the Controversial C5a Receptor C5aR2: Its Role in Health and Disease”

Ting Zhang,Malgorzata A. Garstka,Ke Li

DOI: https://doi.org/10.1155/2017/6073961

IF: 4.4929

2017-01-01

Journal of Immunology Research

Abstract:[This corrects the article DOI: 10.1155/2017/8193932.].
Corrigendum to “Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling”

Chenyang Zhao,Jinlan Gao,Sen Li,Qi Liu,Xiaoyu Hou,Shenghuan Liu,Xuesha Xing,Manni Sun,Shusen Wang,Yang Luo

DOI: https://doi.org/10.1155/2019/4104265

2019-01-01

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2018/6938482.].

Corrigendum: Galectin-9: A Suppressor of Atherosclerosis?

Corrigendum: Adiponectin Modified BMSCs Alleviate Heart Fibrosis Via Inhibition TGF-beta1/smad in Diabetic Rats

Corrigendum: Alternative Splicing: a New Cause and Potential Therapeutic Target in Autoimmune Disease.

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes &amp; Diseases 9(2022) 443–455]

Corrigendum: C1q/TNF-Related Protein 9 Attenuates Atherosclerosis by Inhibiting Hyperglycemia-Induced Endothelial Cell Senescence Through the AMPKα/KLF4 Signaling Pathway

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis.

Corrigendum: LYG1 Deficiency Attenuates the Severity of Acute Graft-Versus-Host Disease via Skewing Allogeneic T Cells Polarization Towards Treg Cells

Corrigendum: CircAFF1 aggravates vascular endothelial cell dysfunction mediated by miR-516b/SAV1/YAP1 axis

Corrigendum: Myocardial Viability, Functional Status, and Collaterals of Patients With Chronically Occluded Coronary Arteries

Corrigendum to"Synergistically targeting synovium STING pathway for rheumatoid arthritis treatment" [Bioact Mater 24 (2022) 37-53]

Corrigendum: Akkermansia muciniphila suppressing nonalcoholic steatohepatitis associated tumorigenesis through CXCR6+ natural killer T cells

Corrigendum to “Lipopolysaccharide-induced podocyte injury is regulated by calcineurin/NFAT and TLR4/MyD88/NF-κB signaling pathways through Angiopoietin-like protein 4” [Genes & Diseases 9(2022) 443-455]

Corrigendum: the Adipocyte and Adaptive Immunity

Galectin-9: A Suppressor of Atherosclerosis?

Corrigendum: The Emerging Role of Rho Guanine Nucleotide Exchange Factors in Cardiovascular Disorders: Insights Into Atherosclerosis: A Mini Review

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer.

Corrigendum: The cholesterol-binding sequence in monomeric C-reactive protein binds to the SARS-CoV-2 spike receptor-binding domain and blocks interaction with Angiotensin-converting enzyme 2

Corrigendum to “Suppression of IL-6 Gene by shRNA Augments Gemcitabine Chemosensitization in Pancreatic Adenocarcinoma Cells”

Corrigendum: 9-PAHSA Improves Cardiovascular Complications by Promoting Autophagic Flux and Reducing Myocardial Hypertrophy in Db/Db Mice

Corrigendum to “the Controversial C5a Receptor C5aR2: Its Role in Health and Disease”

Corrigendum to “Cyclin G2 Suppresses Glomerulosclerosis by Regulating Canonical Wnt Signalling”

Corrigendum to “Lipopolysaccharide-Induced Podocyte Injury is Regulated by Calcineurin/nfat and TLR4/MyD88/NF-κB Signaling Pathways Through Angiopoietin-like Protein 4” [genes & Diseases 9(2022) 443–455]